Benjamin Djulbegovic, M.D., Ph.D.

bdjulbegovic@coh.org
626-256-4673
Benjamin Djulbegovic
Professor, Department of Hematology & Hematopoietic Cell Transplantation; Professor, Department of Computational and Quantitative Medicine
Clinical Expertise
Hematological Diseases
Evidence-based Medicine
Decision Sciences
Clinical Practice Guidelines
Research Area
Clinical Research Methodology
Evidence-based Medicine
Decision Sciences
Clinical Practice Guidelines
Hematologic Malignancies
Appointments
Professor and Director of Research, Department of Supportive Care Medicine
Director of Evidence-based Medicine and Comparative Effectiveness Research
Clinical Teams
Hematology & Hematopoietic Cell Transplantation
Supportive Care Medicine

Benjamin Djulbegovic, M.D., Ph.D., is a professor in the departments of Hematology & Hematopoietic Cell Transplantation and Computational and Quantitative Medicine, professor and director of research in the Department of Supportive Care Medicine, and medical director of evidence-based analytics, a newly established core program at City of Hope.

His main academic and research interest lies in attempts to measure and optimize clinical research and practice of medicine by understanding both nature of medical evidence and decision-making. To this effect, his work aims to integrate methods and techniques across evidence-based medicine (EBM), predictive analytics, health outcome research and decision-sciences. The role of uncertainty and rationality in science and clinical medicine has been one of the common themes across his work, particularly evident in his analysis of equipoise and the role of regret.

Dr. Djulbegovic has systematically applied science of EBM and decision analysis to the entire fields of hematology and oncology that resulted in two books; the book on “Reasoning and Decision-making in Hematology” was listed one of the best books by the Journal of the National Cancer Institute and the book “Decision Making in Oncology. Evidence-based Management” was assessed as “one of the first and best attempts to apply an evidence-based approach to the practice of medical oncology.”

As of September 2017, he has published 310 papers in peer-review journals, 190 abstracts and numerous book chapters. He also received several awards for his work, which has also been published in major scientific and medical journals including Nature, Lancet, JAMA, New England Journal of Medicine, etc. He has also widely taught on these subjects. During last 20 years, Dr. Djulbegovic has received continuous external funding by both federal and private entities. He was also selected in Newsweek’s list of "Top Cancer Doctors" and since 2011 continuously selected in the top 1% of U.S. doctors by U.S. News & World Report in the field of hematology.

Location
Education & Experience
Board Certifications

  • Internal Medicine

  • Hematology

Degrees

  • 1987, Ph.D., Biomedical Sciences, University of Sarajevo

  • 1983, M.S., Biophysics, University of Zagreb

  • 1976, M.D., Medicine, University of Sarajevo

Fellowship

  • 1991, hematology and oncology, University of Louisville

Residency

  • 1988, Internal Medicine, University of Louisville

Professional Experience

  • 2017-present, Professor, Departments of Supportive Care Medicine and Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

  • 2014-2017, Associate Dean for Comparative Effectiveness Research, USF, Tampa, FL

  • 2012-2013, Associate Dean for Clinical Research, USF, Tampa, FL

  • 2012-2013, Director, Clinical and Translational Institute, USF, Tampa, FL

  • 2010-2017, Chief, Division of Evidence-Based Medicine and Health Outcomes Research, Tampa, FL

  • 2008-2011, Co-Director, Clinical and Translational Institute, USF College of Medicine, Tampa, FL

  • 2008-2011, Director, Center for Evidence-Based Medicine, USF College of Medicine, Tampa, FL

  • 2010-2017, Distinguished Professor, USF, Tampa, FL

Awards & Memberships
Awards

  • 2017, Award For Excellence In Person Centered Healthcare (in recognition of substantial efforts to explicate the EBM thesis and to ‘bridge the gap’ between that thesis and the core tenets of person-centered healthcare)

  • Fourth Annual Conference of the European Society for Person Centered Healthcare (ESPCH4), Westminster Cathedral Hall, London, October 26-27, 2017

  • 2014, USF Allan L. Goldman Lifetime Contribution to Research Award

  • 2103, USF Faculty Outstanding Research Achievement Award

  • 2011, Principle investigator and senior author on the paper (“True methodological quality of trials are not reflected in their reporting” by Mhaskar R, Soares H, Kumar A, Djulbegovic B, which received The Thomas C. Chalmers Award (first prize) at the 19th Annual Cochrane Colloquium, Madrid

  • 2007, H. Lee Moffitt Cancer Center & Research Institute Publication

  • Award to the scientist with publication with highest average impact factor

  • 1999, The Tomas C. Chalmers Award (second prize), for the work “empirical verification of the uncertainty principle in the conduct of randomized trials.” (Djulbegovic B, Lacevic M, Lyman GH). VII Cochrane Colloquium: The Best Evidence for Health Care, Rome

  • 1997, Award for the first place for the paper “Regret in Clinical Decision Making” at the Second Annual Medical Research Competition, Research, Louisville

Publications